乳腺癌生物标志物钙网蛋白的核酸适配体筛选及血清检测和乳腺癌细胞识别

孙淼 杨歌 赵毅 屈锋

引用本文: 孙淼,  杨歌,  赵毅,  屈锋. 乳腺癌生物标志物钙网蛋白的核酸适配体筛选及血清检测和乳腺癌细胞识别[J]. 分析化学, 2020, 48(5): 642-649. doi: 10.19756/j.issn.0253-3820.201004 shu
Citation:  SUN Miao,  YANG Ge,  ZHAO Yi,  QU Feng. Screening of Aptamer for Breast Cancer Biomarker Calreticulin and Its Application to Detection of Serum and Recognition of Breast Cancer Cell[J]. Chinese Journal of Analytical Chemistry, 2020, 48(5): 642-649. doi: 10.19756/j.issn.0253-3820.201004 shu

乳腺癌生物标志物钙网蛋白的核酸适配体筛选及血清检测和乳腺癌细胞识别

  • 基金项目:

    本文系国家自然基科学金项目(Nos.21675012,21874010,21827810)资助

摘要: 钙网蛋白(CRT)与许多癌症的发生密切相关,被认为是乳腺癌侵袭和转移的有效新型生物标志物以及乳腺癌分期和预后的评价指标。本研究利用毛细管电泳-指数富集配体进化技术(CE-SELEX)筛选并鉴定了CRT的核酸适配体。毛细管电泳法、等温滴定量热法及纳米金比色法表征结果表明,适配体Apt 23对CRT具有较高的亲和力和特异性。FAM标记的Apt 23(FAM-Apt 23)可用作毛细管电泳的亲和探针,采用激光诱导荧光检测器,检测血清中CRT的浓度范围为1~1000 nmol/L,检出限为0.5 nmol/L。FAM-Apt 23也可用作CRT的免疫荧光成像探针,可结合在CRT过表达的乳腺癌细胞4T1的表面。初步研究结果表明,利用毛细管电泳筛选的核酸适配体Apt 23可用于CRT识别和检测的探针。

English


    1. [1]

      Smith M J, Koch G L. EMBO J.,1989,8(12): 3581-3586

    2. [2]

      Païdassi H, Tacnet-Delorme P, Verneret M, Gaboriaud C, Houen G, Duus K, Ling W L, Arlaud G J, Frachet P. J. Mol. Biol.,2011,408(2): 277-290

    3. [3]

      Eggleton P, Bremer E, Dudek E, Michalak M. Expert Opin. Ther. Tar.,2016,20(9): 1137-1147

    4. [4]

      Chiang W F, Hwang T Z, Hour T C, Wang L H, Chiu C C, Chen H R, Wu Y J, Wang C C, Wang L F, Chien C Y, Chen J H, Hsu C T, Chen J Y. Oral Oncol.,2013,49(6): 534-541

    5. [5]

      Song M N, Moon P G, Lee J E, Na M, Kang W, Chae Y S, Park J Y, Park H, Baek M C. Arch. Pharm. Res.,2012,35(10): 1839-1847

    6. [6]

      Lee H H, Lim C A, Cheong Y T, Singh M, Gam L H. Int. J. Biol. Sci.,2012,8(3): 353-362

    7. [7]

      Zamanian M, Hamadneh L A Q, Veerakumarasivam A, Rahman S A, Shohaimi S, Rosli R. Cancer Cell Int.,2016,16(1): 56

    8. [8]

      Lwin Z M, Guo C, Salim A, Yip G W, Chew F T, Nan J, Thike A A, Tan P H, Bay B H. Modern Pathol.,2010,23(12): 1559-1566

    9. [9]

      Chen C N, Chang C C, Su T E, Hsu W M, Jeng Y M, Ho M C, Hsieh F J, Lee P H, Kuo M L, Lee H, Chang K J. Ann. Surg. Oncol.,2009,16(2): 524-533

    10. [10]

      Alfonso P, Núñez A, Madoz-Gurpide J, Lombardia L, Sánchez L, Casal J I. Proteomics,2005,5(10): 2602-2611

    11. [11]

      Minami S, Nagashio R, Ueda J, Matsumoto K, Goshima N, Hattori M, Hachimura K, Iwamura M, Sato Y. Biomed. Res.,2014,35(1): 25-35

    12. [12]

      Sheng W, Chen C, Dong M, Zhou J, Liu Q, Dong Q, Li F. J. Cell. Physiol.,2014,229(7): 887-897

    13. [13]

      Alaiya A, Roblick U, Egevad L, Carlsson A, Franzén B, Volz D, Huwendiek S, Linder S, Auer G. Anal. Cell. Pathol.,2000,21(1): 1-9

    14. [14]

      Hellman K, Alaiya A A, Schedvins K, Steinberg W, Hellström A C, Auer G. Brit. J. Cancer,2004,91(2): 319-326

    15. [15]

      Lu Y C, Weng W C, Lee H. Biomed. Res. Int.,2015:526524

    16. [16]

      Ni M, Wei W, Wang Y, Zhang N, Ding H, Shen C, Zheng F. J. Clin. Immunol.,2013,33(5): 947-953

    17. [17]

      Xu Q, Chen C, Chen G, Chen W, Zhou D, Xie Y. Oncol. Lett.,2018,15(6): 8999-9008

    18. [18]

      Fucikova J, Becht E, Iribarren K, Goc J, Remark R, Damotte D, Alifano M, Devi P, Biton J, Germain C, Lupo A, Fridman W H, Dieu-Nosjean M C, Kroemer G, Fridman C S, Cremer I. Cancer Res.,2016,76(7): 1746-1756

    19. [19]

      Ellington A D, Szostak J W. Nature,1990,346(6287): 818-822

    20. [20]

      Tuerk C, Gold L. Science,1990,249(4968): 505-510

    21. [21]

      Zhou G, Wilson G, Hebbard L, Duan W, Liddle C, George J, Qiao L. Oncotarget,2016, 7: 13446-13463

    22. [22]

      Mercier M C, Dontenwill M, Choulier L. Cancers,2017,9(12): 69

    23. [23]

      Bayat P, Nosrati R, Alibolandi M, Rafatpanah H, Abnous K, Khedri M, Ramezani M. Biochimie,2018,154: 132-155

    24. [24]

      Dong L, Tan Q, Ye W, Liu D L, Chen H F, Hu H W, Wen D, Liu Y, Cao Y, Kang J W, Fan J, Guo W, Wu W Z. Sci. Rep.,2015,5: 15552

    25. [25]

      Zhu C, Li L S, Yang G, Irfan M, Wang Z J, Fang S B, Qu F. Talanta,2019,205: 120088

    26. [26]

      Berezovski M, Krylov S N. J. Am. Chem. Soc.,2002,124(46):13674-13675

    27. [27]

      Mendonsa S D, Bowser M T. Anal. Chem.,2004,76(18): 5387-5392

    28. [28]

      Mendonsa S D, Bowser M T. J. Am. Chem. Soc.,2005,127(26): 9382-9383

    29. [29]

      Mosing R K, Mendonsa S D, Bowser M T. Anal. Chem.,2005,77(19): 6107-6112

    30. [30]

      Wang J, Gao Z P, Qin S, Liu C B, Zou L L. Exp. Ther. Med.,2017,14(4): 3399-3406

    31. [31]

      Qin S, Gao Z, Liu Y, Liu C, Wang J, Zou L L. Oncol. Lett.,2017,15(2): 1630-1638

    32. [32]

      Beebe S J, Lassiter B P, Guo S. Cancers,2018,10(4): 97

    33. [33]

      Erić A, Juranić Z, Milovanović Z, Marković I, Inić M, Stanojević-Bakić N, Vojinović-Golubović V. Pathol. Oncol. Res.,2009,15(1): 89-90

    34. [34]

      Erić-Nikolić A, Milovanović Z, Sánchez D, Pekáriková A, Džodić R, Matić I Z,Tućková L, Jevrić M, Buta M, Rašković S, Juranić Z. Oncology,2012,82(1): 48-55

  • 加载中
计量
  • PDF下载量:  0
  • 文章访问数:  29
  • HTML全文浏览量:  0
文章相关
  • 收稿日期:  2020-01-03
  • 修回日期:  2020-03-05
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章